- Home
- SEAT vs ORIC Comparison
SEAT vs ORIC Comparison
Compare SEAT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- ORIC
- Stock Information
- Founded
- SEAT 2001
- ORIC 2014
- Country
- SEAT United States
- ORIC United States
- Employees
- SEAT N/A
- ORIC N/A
- Industry
- SEAT Industrial Machinery/Components
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- SEAT Industrials
- ORIC Health Care
- Exchange
- SEAT Nasdaq
- ORIC Nasdaq
- Market Cap
- SEAT 366.2M
- ORIC 362.9M
- IPO Year
- SEAT N/A
- ORIC 2020
- Fundamental
- Price
- SEAT $1.93
- ORIC $10.71
- Analyst Decision
- SEAT Buy
- ORIC Strong Buy
- Analyst Count
- SEAT 11
- ORIC 9
- Target Price
- SEAT $4.49
- ORIC $18.29
- AVG Volume (30 Days)
- SEAT 1.4M
- ORIC 987.5K
- Earning Date
- SEAT 08-05-2025
- ORIC 08-11-2025
- Dividend Yield
- SEAT N/A
- ORIC N/A
- EPS Growth
- SEAT N/A
- ORIC N/A
- EPS
- SEAT N/A
- ORIC N/A
- Revenue
- SEAT $748,757,000.00
- ORIC N/A
- Revenue This Year
- SEAT N/A
- ORIC N/A
- Revenue Next Year
- SEAT $4.42
- ORIC N/A
- P/E Ratio
- SEAT N/A
- ORIC N/A
- Revenue Growth
- SEAT 0.82
- ORIC N/A
- 52 Week Low
- SEAT $1.44
- ORIC $3.90
- 52 Week High
- SEAT $5.74
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- SEAT 54.56
- ORIC 67.12
- Support Level
- SEAT $1.82
- ORIC $10.42
- Resistance Level
- SEAT $2.06
- ORIC $11.14
- Average True Range (ATR)
- SEAT 0.14
- ORIC 0.59
- MACD
- SEAT 0.04
- ORIC -0.08
- Stochastic Oscillator
- SEAT 70.65
- ORIC 79.49
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.